Arteriosclerosis: New Insights into Pathogenetic Mechanisms and Prevention

Arteriosclerosis: New Insights into Pathogenetic Mechanisms and Prevention

Paperback(Softcover reprint of the original 1st ed. 1994)

Want it by Wednesday, November 21 Order now and choose Expedited Shipping during checkout.

Product Details

ISBN-13: 9783642856624
Publisher: Springer-Verlag New York, LLC
Publication date: 02/17/2012
Edition description: Softcover reprint of the original 1st ed. 1994
Pages: 202
Product dimensions: 6.69(w) x 9.61(h) x 0.02(d)

Table of Contents

Arteriosclerosis: Its morphology in the past and today.- Changes in components and structure of atherosclerotic lesions developing from childhood to middle age in coronary arteries.- Lipid and cellular constituents of unstable human aortic plaques.- Immunological control mechanisms in plaque formation.- Proliferation versus atrophy - the ambivalent role of smooth muscle cells in human atherosclerosis.- Extracellular matrix degrading metalloproteinases in the pathogenesis of arteriosclerosis.- Vascular renin-angiotensin-system, endothelial function and atherosclerosis?.- Endothelial dysfunction in atherosclerosis.- New determinants of the uptake of atherogenic plasma proteins by arteries.- Hyperlipidemic endothelial injury and angiogenesis.- Assessment of endothelial modulation of coronary vasomotor tone: Insights into a fundamental functional disturbance in vascular biology of atherosclerosis.- In vitro assessment of luminal dimensions of coronary arteries by intravascular ultrasound with and without application of echogenic contrast dye.- Therapeutic approaches to the control of coronary atherosclerosis.- Role of calcium in arteriosclerosis - Experimental evaluation of antiarteriosclerotic potencies of Ca antagonists.- Role of calcium antagonists in progression of arteriosclerosis. Evidence from animal experiments and clinical experience..- I: Preventive effects of calcium antagonists in animal experiments.- II: Clinical experience with preventive effects of calcium channel blockers in atheromatous coronary artery disease.- Lipid-lowering therapy - Implications for the prevention of atherosclerosis.

Customer Reviews

Most Helpful Customer Reviews

See All Customer Reviews